Researchers have concluded that ANXA1 acts as a tumour suppressor in head and neck squamous cell carcinoma (HNSCC) and could be an important prognostic biomarker (Raulf et al., 2018). This evidence concerns the gene ANXA1 and head and neck squamous cell carcinoma.